iBio News - IBIO

Company Name	Stock Ticker Symbol	Market	Type
iBio Inc	IBIO	AMEX	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.01	-3.23%	0.30	19:55:32

Open Price	Low Price	High Price	Close Price	Prev Close
0.3101	0.2916	0.3204	0.2975	0.31

more quote information »

Recent News

Date	Time	Source	Heading
9/21/2023	16:05	GLOBE	iBio Announces Amendment to Credit Agreement with Woodforest
9/21/2023	08:00	EDGAR2	Form 8-K - Current report
8/30/2023	16:22	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/24/2023	16:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/24/2023	16:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/15/2023	16:02	EDGAR2	Form D - Notice of Exempt Offering of Securities
8/14/2023	16:15	GLOBE	iBio Reports Triple Milestone: In Vivo Proof-of-Concept for..
8/14/2023	15:21	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
8/07/2023	16:01	EDGAR2	Form 8-K - Current report
8/07/2023	09:29	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/04/2023	16:47	EDGAR2	Form 8-K - Current report
7/28/2023	16:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/13/2023	16:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/10/2023	08:29	EDGAR2	Form 8-K - Current report
6/27/2023	08:00	GLOBE	iBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO..
6/12/2023	16:15	GLOBE	iBio Forges Research Collaboration with the National..
6/06/2023	08:00	GLOBE	iBio Expands Tech Stack with EngageTx™; Adds TROP-2..
5/09/2023	16:30	GLOBE	iBio to Participate in the JMP Securities Life Sciences..
4/04/2023	16:05	GLOBE	iBio Discovers New Panel of CD3 T-Cell Binding Antibodies..
3/31/2023	08:10	GLOBE	iBio Advances Anti-CCR8 Antibody Program to Preclinical In..
2/16/2023	16:47	GLOBE	iBio Announces MUC16 as its Latest Immune-Oncology Target..
1/05/2023	08:00	GLOBE	iBio Announces Issuance of U.S. Patent Covering..
12/09/2022	16:05	GLOBE	iBio Announces Closing of $3.5 Million Underwritten Public..
12/06/2022	23:27	GLOBE	iBio Announces Pricing of $3.5 Million Underwritten Public..
12/06/2022	16:01	GLOBE	iBio Announces Proposed Underwritten Public Offering
12/06/2022	08:00	GLOBE	iBio to Participate in the JMP Securities Hematology and..
12/05/2022	08:00	GLOBE	iBio® to Showcase the RubrYc® Discovery Engine During Poster..
12/02/2022	16:30	GLOBE	iBio Announces CEO Departure
11/03/2022	08:00	GLOBE	iBio Accelerates Transformation to AI-Powered Biotech
9/28/2022	00:25	TRMN	Ibio (IBIO) Receives a Buy from JMP Securities
9/27/2022	16:10	GLOBE	iBio Reports Preliminary Unaudited Fiscal Year 2022..